Grant ID

01T-067

Illness

Schizophrenia

Primary Drug/Intervention

Mirtazapine

Primary Dosage

30 mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Joffe

Sample Size

40

Duration of Study Period for Each Subject

6 weeks

Outcome Measurements

PANSS, CGI, Simpson-Angus

Results

Mirtazapine was significantly superior to placebo on PANSS (effect size 0.97) positive and negative scales.

Publication

Joffe G1, Terevnikov V, Joffe M, Stenberg JH, Burkin M, Tiihonen J. Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial. Schizophr Res. 2009 Mar;108(1-3):245-51.

Link

http://www.ncbi.nlm.nih.gov/pubmed/19144501

PI Name

Grigori Joffe

Degree

MD

Center

N/A

Institution

Psychiatric Hospital of Kellokoski

Address

City or Town

Kellokoski

State or Province

N/A

Zip or Postal Code

4500

Country

Finland

Email Address

grigori.joffe@hus.fi